Vanda Pharmaceuticals (VNDA) EBIT Growth (5y) (2015 - 2026)
Vanda Pharmaceuticals (VNDA) EBIT Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Vanda Pharmaceuticals | 318.71 Mn | 116.40 Mn | 48.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -46.97% |
| Dec 31, 2025 | -42.43% |
| Sep 30, 2025 | -43.29% |
| Jun 30, 2025 | -44.03% |
| Mar 31, 2025 | -218.59% |
| Dec 31, 2024 | -34.63% |
| Sep 30, 2024 | -24.76% |
| Jun 30, 2024 | -24.78% |
| Mar 31, 2024 | -34.64% |
| Dec 31, 2023 | -22.65% |
| Sep 30, 2023 | -24.25% |
| Jun 30, 2023 | -22.27% |
| Mar 31, 2023 | -3.88% |
| Dec 31, 2022 | 38.43% |
| Sep 30, 2022 | 22.81% |
| Jun 30, 2022 | 30.60% |
| Mar 31, 2022 | 0.61% |
| Dec 31, 2021 | 72.34% |
| Sep 30, 2021 | 79.37% |
| Jun 30, 2021 | 35.59% |